镓-67 DFO-DAS-纤维蛋白原的临床应用。
Clinical use of Ga-67 DFO-DAS-fibrinogen.
作者信息
Yamamoto K, Torizuka K
机构信息
Department of Radiology and Nuclear Medicine, Faculty of Medicine, Kyoto University, Japan.
出版信息
Radiat Med. 1987 Sep-Oct;5(5):180-2.
The clinical usefulness of 67Ga-DFO-DAS-fibrinogen, a newly developed thrombus imaging agent, was evaluated. Fifteen cases were given 2 mCi of 67Ga-DFO-DAS-fibrinogen and images were obtained up to 96 hours after injection. Abnormal accumulation of 67Ga-DFO-DAS-fibrinogen was imaged in seven cases with either venous or arterial thrombi, and no side effects were noted. These results suggested that 67Ga-DFO-DAS-fibrinogen might be a promising agent for thrombus imaging.
对新开发的血栓显像剂67Ga-DFO-DAS-纤维蛋白原的临床实用性进行了评估。15例患者接受了2毫居里的67Ga-DFO-DAS-纤维蛋白原，并在注射后96小时内进行显像。7例静脉或动脉血栓患者的67Ga-DFO-DAS-纤维蛋白原出现异常聚集，且未观察到副作用。这些结果表明，67Ga-DFO-DAS-纤维蛋白原可能是一种有前景的血栓显像剂。
Zotero 插件